low estrogen [fndg]
Dose [qnco]
Progestogen hormone therapy [topp]
Replacement [topp]
randomized [resa]
Trial [resa]
Objective [inpr]
To [qlco]
establish [qlco]
Efficacy [qlco]
acceptability [qlco]
Combined [qlco]
Continuous [idcn]
low estrogen [fndg]
Dose [qnco]
Low dose [qnco]
Progestagen [horm, phsu, strd]
therapy [ftcn]
To [qlco]
Three [qnco]
Available [ftcn]
Progestogens [horm, phsu, strd]
Low dose [qnco]
effective [qlco]
Estrogen [horm, phsu, strd]
Affected [ftcn]
Outcome [ftcn]
Measured [qlco]
Design [acty]
month [tmco]
prospective [resa]
OPEN LABEL [resa]
Single [popg]
Center [spco]
Trial [resa]
Patients [podg]
Methods [inpr]
Five [qnco]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
Hormone replacement therapy [topp]
Form [qlco]
Conjugated oestrogens [horm, phsu, strd]
Equine [mamm]
cee [orch]
mg% [qnco]
Daily [tmco]
Cyclical [tmco]
medroxyprogesterone acetate [horm, phsu, strd]
mg% [qnco]
experience [menp]
Withdrawal bleeding [dsyn]
Changed [ftcn]
Continuous [idcn]
Daily [tmco]
Regimen [topp]
mg% [qnco]
cee [orch]
Random Allocation [resa]
One [qnco]
Three [qnco]
Low dose [qnco]
Progestogens [horm, phsu, strd]
Levonorgestrel [horm, phsu, strd]
Norethisterone [horm, phsu, strd]
Return [qlco]
Dose [qnco]
mg% [qnco]
cee [orch]
permitted [fish]
Required [ftcn]
To [qlco]
Control [grup]
menopausal symptoms [sosy]
Separate [spco]
Analysis [lbpr]
Group [idcn]
Appropriate [qlco]
Outcome [ftcn]
Measured [qlco]
Menopausal symptom [sosy]
Score [qnco]
Clinical [qlco]
Bleeding [patf]
Pattern [spco]
endometrial biopsy [diap]
Result [ftcn]
Forearm bone [bpoc]
density [qnco]
Content [menp]
Serum lipids NOS [lbpr]
side effects [ftcn]
Result [ftcn]
Women [popg]
Withdraw [acty]
Trial [resa]
Five [qnco]
Irregular bleeding NOS [sosy]
Amenorrhea [dsyn]
Three [qnco]
months [tmco]
Six [qnco]
months [tmco]
months [tmco]
endometrial biopsy [diap]
Show [inpr]
Atrophic endometrium [fndg]
months [tmco]
One [qnco]
Minimal [qlco]
proliferative [patf]
activity [dora]
Seen [qlco]
twenty [orch, phsu]
Seven [qnco]
Women [popg]
Choose [acty]
To [qlco]
Return [qlco]
Dose [qnco]
mg% [qnco]
cee [orch]
Group [idcn]
Final [tmco]
Control [grup]
symptoms [ftcn]
Improved [qlco]
regimens [inpr]
Bone [bpoc]
Lipid [lipd]
Profile [lbpr]
Unchanged [fndg]
Minimal [qlco]
side effects [ftcn]
experience [menp]
Patients [podg]
Little NOS [cgab, dsyn]
Outcome [ftcn]
Three [qnco]
Progestogens [horm, phsu, strd]
Norethisterone [horm, phsu, strd]
therapy [ftcn]
Associated [qlco]
Prevalence [qnco]
Amenorrhea [dsyn]
Six [qnco]
months [tmco]
Seen [qlco]
Levonorgestrel [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
Group [idcn]
Conclusions [idcn]
low estrogen [fndg]
Dose [qnco]
Continuous [idcn]
Progestagen [horm, phsu, strd]
regimens [inpr]
APPEAR [qlco]
Appropriate [qlco]
Option [ftcn]
postmenopausal [tmco]
Woman [popg]
WISH [gngm]
Withdrawal bleeding [dsyn]
Hormonal [qlco]
side effects [ftcn]
menopausal symptoms [sosy]
Long-term [tmco]
Benefit [qnco]
regimens [inpr]
Prevention [topp]
Osteoporotic Fractures [dsyn]
Cardiovascular disease [dsyn]
Endometrial Cancer [neop]
Need [qlco]
To [qlco]
Further [spco]
Assessed [acty]
Time [tmco]
